Top

Maxillofacial Plastic and Reconstructive Surgery

Published in:

Open Access 01-12-2016 | Editorial

Botulinum toxin related research in maxillofacial plastic and reconstructive surgery

Author: Tae-Geon Kwon

Published in: Maxillofacial Plastic and Reconstructive Surgery | Issue 1/2016

Excerpt

Botulism caused by food poisoning was characterized by mydriasis and skeletal muscle paralysis, which was first described by Justinus Kerner in 1820 [1]. The cause of botulism was botulinum neurotoxin produced by anaerobic, spore-forming bacteria of the genus Clostridium [2]. Botulinum toxin (BTX) became to be the first medically applied toxin. The first clinical use of BTX was reported concerning the treatment of strabismus in ophthalmologic field in 1980 [3]. Nine years later, the Food and Drug Administration (FDA) approved the clinical application of BTX for adult strabismus and blepharospasm [4]. BTX inhibits acetylcholine exocytosis at neuromuscular junction of the preganglionic sympathetic/parasympathetic nerve fibers and postganglionic parasympathetic nerves [5]. …

Lu DW, Lippitz J (2009) Complications of botulinum neurotoxin. Dis Mon 55:198–211CrossRefPubMed

Popoff MR, Bouvet P (2013) Genetic characteristics of toxigenic Clostridia and toxin gene evolution. Toxicon 75:63–89CrossRefPubMed

Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87:1044–1049CrossRefPubMed

Scott AB (2004) Development of botulinum toxin therapy. Dermatol Clin 22:131–133CrossRefPubMed

Khanna S, Jain S (2006) Botox: the poison that heals. Int Dent J 56:356–358CrossRefPubMed

de Maio M (2008) Therapeutic uses of botulinum toxin: from facial palsy to autonomic disorders. Expert Opin Biol Ther 8:791–798CrossRefPubMed

Jaspers GW, Pijpe J, Jansma J (2011) The use of botulinum toxin type A in cosmetic facial procedures. Int J Oral Maxillofac Surg 40:127–133CrossRefPubMed

Ihde SK, Konstantinovic VS (2007) The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:e1–e11CrossRefPubMed

Jeong CH, Ryu JY, Lee WY, Kim HM (2015) Simultaneous surgery for subcondylar fracture and prominent angle of the mandible. Maxillofac Plast Reconstr Surg 37:26CrossRefPubMedPubMedCentral

10.

Lee CJ, Kim SG, Kim YJ, Han JY, Choi SH, Lee SI (2007) Electrophysiologic change and facial contour following botulinum toxin A injection in square faces. Plast Reconstr Surg 120:769–778CrossRefPubMed

11.

Kim HS, Yun PY, Kim YK (2016) A clinical evaluation of botulinum toxin-A injections in the temporomandibular disorder treatment. Maxillofac Plast Reconstr Surg 38:5CrossRefPubMedPubMedCentral

12.

Su JZ, Cai ZG, Yu GY (2015) Microvascular autologous submandibular gland transplantation in severe cases of keratoconjunctivitis sicca. Maxillofac Plast Reconstr Surg 37:5CrossRefPubMedPubMedCentral

13.

Zhang DZ, Liu XY, Xiao WL, Xu YX (2016) Botulinum toxin type A and the prevention of hypertrophic scars on the maxillofacial area and neck: a meta-analysis of randomized controlled trials. PLoS One 11:e0151627CrossRefPubMedPubMedCentral

14.

Srivastava S, Kharbanda S, Pal US, Shah V (2015) Applications of botulinum toxin in dentistry: a comprehensive review. Natl J Maxillofac Surg 6:152–159CrossRefPubMedPubMedCentral

15.

Garcia RM, Hadlock TA, Klebuc MJ, Simpson RL, Zenn MR, Marcus JR. Contemporary solutions for the treatment of facial nerve paralysis (2015) Plast Reconstr Surg 135:1025e-1046e. doi:10.1097/PRS.0000000000001273.

16.

Sinclair CF, Gurey LE, Blitzer A (2013) Oromandibular dystonia: long-term management with botulinum toxin. Laryngoscope 123:3078–3083CrossRefPubMed

17.

Bhogal PS, Hutton A, Monaghan A (2006) A review of the current uses of Botox for dentally-related procedures. Dent Update 33:165–168PubMed

18.

Niamtu J 3rd (2003) Botulinum toxin A: a review of 1,085 oral and maxillofacial patient treatments. J Oral Maxillofac Surg 61:317–324CrossRefPubMed

19.

Hoque A, McAndrew M (2009) Use of botulinum toxin in dentistry. N Y State Dent J 75:52–55PubMed

20.

Archana MS (2016) Toxin yet not toxic: botulinum toxin in dentistry. Saudi Dent J 28:63–69CrossRefPubMed

21.

Cote TR, Mohan AK, Polder JA, Walton MK, Braun MM (2005) Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 53:407–415CrossRefPubMed

Title: Botulinum toxin related research in maxillofacial plastic and reconstructive surgery
Author: Tae-Geon Kwon
Publication date: 01-12-2016
Publisher: Springer Berlin Heidelberg
Published in: Maxillofacial Plastic and Reconstructive Surgery / Issue 1/2016
Electronic ISSN: 2288-8586
DOI: https://doi.org/10.1186/s40902-016-0080-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Botulinum toxin related research in maxillofacial plastic and reconstructive surgery

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2016

Mixed-reality simulation for orthognathic surgery

Utility of sodium tetradecyl sulfate sclerotherapy from benign oral vascular lesion

Supernumerary nostril: a case report

Analysis of morbidity, mortality, and risk factors of tracheostomy-related complications in patients with oral and maxillofacial cancer

Posterior maxillary segmental osteotomy for management of insufficient intermaxillary vertical space and intermolar width discrepancy: a case report

Retrospective clinical study of ultrawide implants more than 6 mm in diameter